Projects

  • How does HCV affect lipid metabolism in infected liver cells?
  • The role of calsyntenin-1 in the HCV replication cycle.
  • HCV resistance mutations against direct acting antivirals (DAAs).
  • Psychosocial Predictors of HCV treatment Adherence and Completion.
  • The role of endocannabinoid receptor CB1 in liver fibrosis.
  • Targeting nuclear export - a novel antiviral strategy against hepatitis C virus.
  • The role of COPI and Golgi-ER trafficking in HCV replication.
  • Mitochondrial changes in HCV infected hepatocytes.
  • HCV-induced changes in beta actin and effects on cell motility.
  • Characterisation of ARL6IP5 in hepatitis C-related liver cancer.
  • IFNL and MERTK SNPs and liver fibrosis.
  • CB1 antagonists as supplementary antivirals against HCV.